An Observational Study of Avastin and Conventional Chemotherapy in Patients >/= 70 Years of Age With Previously Untreated Metastatic Colorectal Cancer (AVAPLUS)

Hoffmann-La Roche256 enrolled

Overview

This observational study will evaluate the use of Avastin (bevacizumab) and conventional chemotherapy in patients \>/= 70 years of age with previously untreated metastatic colorectal cancer. Data will be collected from each patient from initiation of treatment until disease progression occurs (minimum follow-up 12 months).

Study Type

OBSERVATIONAL

Enrollment

256

Conditions

Colorectal Cancer

Eligibility

Sex: ALLMin age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients, \>/ 70 years of age * Previously untreated metastatic colorectal cancer * Patient considered suitable to receive chemotherapy with or without Avastin Exclusion Criteria: * Participation in any other clinical trial or study with the exception of participation in registries

Locations (33)

Unnamed facility

Aalst, Belgium

Unnamed facility

Antwerp, Belgium

Outcomes

Primary Outcomes

Treatment duration in patients receiving chemotherapy with Avastin as first-line therapy in daily clinical practice